Westfield Capital Management
RVMD icon

Westfield Capital Management’s Revolution Medicines RVMD Stock Holding History

Westfield Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Sell
600,821
-955,757
-61% -$140M 0.37% 79
2026
Q1 		$151M Sell
1,556,578
-1,288,435
-45% -$130M 0.64% 34
2025
Q4 		$227M Buy
2,845,013
+331,046
+13% +$21.7M 0.94% 16
2025
Q3 		$117M Buy
2,513,967
+864,563
+52% +$33.9M 0.49% 49
2025
Q2 		$60.7M Buy
1,649,404
+585,358
+55% +$22.5M 0.25% 121
2025
Q1 		$37.6M Buy
1,064,046
+1,058,247
+18,249% +$43M 0.18% 154
2024
Q4 		$254K Buy
+5,799
New +$293K ﹤0.01% 237

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Westfield Capital Management's RVMD Position: Q2 2026 in Review

Westfield Capital Management reduced its Revolution Medicines (RVMD) stake by 61% in Q2 2026, selling an estimated $140M and leaving 600,821 shares worth $113M. The position accounts for 0.37% of the portfolio, ranked #79.

Westfield Capital Management first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $227M in Q4 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Westfield Capital Management held 600,821 shares of Revolution Medicines worth $113M as of Q2 2026.
  • Westfield Capital Management sold 955,757 Revolution Medicines shares in Q2 2026, an estimated $140M.
  • Revolution Medicines made up 0.37% of Westfield Capital Management's portfolio in Q2 2026, its #79 holding.
  • Westfield Capital Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • Westfield Capital Management's Revolution Medicines position peaked at $227M in Q4 2025.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.